{
  "docId": "019de071-e0d6-76fb-ba84-d69d61ac5ee5",
  "docSlug": "1773642d94b9dc79507cf930970e5456",
  "documentTitle": "Certara | Investor Day Presentation Deck | 91 slides",
  "authorId": "certara",
  "authorName": "Certara",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 91,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "key_messages",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The chart shows a clear upward trend in the number of FDA guidances incorporating biosimulation from <2000 to 2020.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-e0d6-76fb-ba84-d69d61ac5ee5/16",
  "deckHref": "/decks/019de071-e0d6-76fb-ba84-d69d61ac5ee5",
  "deckJsonHref": "/decks/019de071-e0d6-76fb-ba84-d69d61ac5ee5.json",
  "deckAnchorHref": "/decks/019de071-e0d6-76fb-ba84-d69d61ac5ee5#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.52,
        "y": 0.29
      },
      "kind": "callout",
      "text": "Model-informed product development aims to integrate information from diverse data sources to help decrease uncertainty and lower failure rates, and to develop information that cannot or would not be generated experimentally.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "05d88164-b5d6-4ffe-a44a-447c95485f4b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.45,
        "x": 0.03,
        "y": 0.215
      },
      "kind": "chart",
      "text": "Incorporation of Biosimulation in FDA Guidances",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c26641cb-669a-4f1f-8244-a7987ce41d60",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.4,
        "x": 0.52,
        "y": 0.59
      },
      "kind": "list",
      "text": "MIDD applications in the report include: Predicting clinical outcomes, Informing trial designs, Supporting evidence for efficacy, Optimizing drug dosing, Predicting product safety",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "19d726f7-0cf2-4e20-8fe1-d1e09b274918",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.52,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "https://www.fda.gov/science-research/advancing-regulatory-science/focus-areas-regulatory-science",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a39c57d3-8cf7-42ee-9382-593b4f121831",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "Increasing regulatory adoption",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b696aa77-642c-48d6-b0bd-fc1d012b2f89",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Authority citation",
      "slug": "authority-citation",
      "agent": null,
      "layer": "slide",
      "matchId": "0233bb84-f045-4185-8818-292105c09b03",
      "evidence": "source-note: https://www.fda.gov/science-research/advancing-regulatory-science/focus-areas-regulatory-science",
      "confidence": 0.7
    },
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "6ffd1638-143b-4bba-989f-c25b15e2bb98",
      "evidence": "chart/bar-vertical: Incorporation of Biosimulation in FDA Guidances",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 12,
      "beatId": "3febb1b1-76b6-4466-a201-7c24a01e3217",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "Pain points in clinical phase and complexity of drug R&D are highlighted",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 12,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "aefb73c8-4528-41b5-be1f-4d7ee4e62081",
      "evidence": "The deck highlights the costs and complexities of traditional drug R&D",
      "position": 0,
      "objective": "What are the costs of not using biosimulation?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}